Merck Tbk (MERK) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Merck Tbk (MERK) has a cash flow conversion efficiency ratio of 0.166x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp137.63 Billion ≈ $8.06 Million USD) by net assets (Rp829.78 Billion ≈ $48.62 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Merck Tbk - Cash Flow Conversion Efficiency Trend (2000–2024)
This chart illustrates how Merck Tbk's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Merck Tbk debt and liabilities for a breakdown of total debt and financial obligations.
Merck Tbk Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Merck Tbk ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Eusu Holdings
KO:000700
|
0.031x |
|
Sedana Medical AB
ST:SEDANA
|
-0.006x |
|
Se Gyung Hi Tech Co.Ltd
KQ:148150
|
0.105x |
|
Nerdy Inc
NYSE:NRDY
|
-0.065x |
|
Crossject
PA:ALCJ
|
2.893x |
|
Yuhwa Sec
KO:003460
|
0.183x |
|
Cube Entertainment Inc
KQ:182360
|
-0.108x |
|
Nonthavej Hospital Public Company Limited
BK:NTV
|
0.041x |
Annual Cash Flow Conversion Efficiency for Merck Tbk (2000–2024)
The table below shows the annual cash flow conversion efficiency of Merck Tbk from 2000 to 2024. For the full company profile with market capitalisation and key ratios, see Merck Tbk market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Rp807.27 Billion ≈ $47.30 Million |
Rp55.71 Billion ≈ $3.26 Million |
0.069x | -73.06% |
| 2023-12-31 | Rp795.88 Billion ≈ $46.64 Million |
Rp203.87 Billion ≈ $11.95 Million |
0.256x | +75.83% |
| 2022-12-31 | Rp757.24 Billion ≈ $44.37 Million |
Rp110.32 Billion ≈ $6.46 Million |
0.146x | -41.31% |
| 2021-12-31 | Rp684.04 Billion ≈ $40.08 Million |
Rp169.81 Billion ≈ $9.95 Million |
0.248x | +111.30% |
| 2020-12-31 | Rp612.68 Billion ≈ $35.90 Million |
Rp71.98 Billion ≈ $4.22 Million |
0.117x | +133.10% |
| 2019-12-31 | Rp594.01 Billion ≈ $34.81 Million |
Rp-210.84 Billion ≈ $-12.35 Million |
-0.355x | -208.88% |
| 2018-12-31 | Rp518.28 Billion ≈ $30.37 Million |
Rp168.96 Billion ≈ $9.90 Million |
0.326x | +54.43% |
| 2017-12-31 | Rp615.44 Billion ≈ $36.06 Million |
Rp129.92 Billion ≈ $7.61 Million |
0.211x | +180.84% |
| 2016-12-31 | Rp582.67 Billion ≈ $34.14 Million |
Rp43.80 Billion ≈ $2.57 Million |
0.075x | -77.85% |
| 2015-12-31 | Rp473.54 Billion ≈ $27.75 Million |
Rp160.70 Billion ≈ $9.42 Million |
0.339x | -19.30% |
| 2014-12-31 | Rp553.69 Billion ≈ $32.44 Million |
Rp232.83 Billion ≈ $13.64 Million |
0.420x | +61.82% |
| 2013-12-31 | Rp512.22 Billion ≈ $30.01 Million |
Rp133.10 Billion ≈ $7.80 Million |
0.260x | +22.49% |
| 2012-12-31 | Rp416.74 Billion ≈ $24.42 Million |
Rp88.40 Billion ≈ $5.18 Million |
0.212x | -32.90% |
| 2011-12-31 | Rp494.18 Billion ≈ $28.96 Million |
Rp156.23 Billion ≈ $9.15 Million |
0.316x | -28.09% |
| 2010-12-31 | Rp363.02 Billion ≈ $21.27 Million |
Rp159.58 Billion ≈ $9.35 Million |
0.440x | +91.60% |
| 2009-12-31 | Rp354.18 Billion ≈ $20.75 Million |
Rp81.26 Billion ≈ $4.76 Million |
0.229x | -27.60% |
| 2008-12-31 | Rp327.32 Billion ≈ $19.18 Million |
Rp103.73 Billion ≈ $6.08 Million |
0.317x | +28.61% |
| 2007-12-31 | Rp280.23 Billion ≈ $16.42 Million |
Rp69.05 Billion ≈ $4.05 Million |
0.246x | -36.50% |
| 2006-12-31 | Rp235.58 Billion ≈ $13.80 Million |
Rp91.42 Billion ≈ $5.36 Million |
0.388x | +79.51% |
| 2005-12-31 | Rp180.38 Billion ≈ $10.57 Million |
Rp38.99 Billion ≈ $2.28 Million |
0.216x | -39.90% |
| 2004-12-31 | Rp154.04 Billion ≈ $9.03 Million |
Rp55.40 Billion ≈ $3.25 Million |
0.360x | -11.02% |
| 2003-12-31 | Rp159.51 Billion ≈ $9.35 Million |
Rp64.48 Billion ≈ $3.78 Million |
0.404x | +113.28% |
| 2002-12-31 | Rp149.25 Billion ≈ $8.75 Million |
Rp28.29 Billion ≈ $1.66 Million |
0.190x | -38.74% |
| 2001-12-31 | Rp127.49 Billion ≈ $7.47 Million |
Rp39.44 Billion ≈ $2.31 Million |
0.309x | -24.27% |
| 2000-12-31 | Rp96.86 Billion ≈ $5.68 Million |
Rp39.57 Billion ≈ $2.32 Million |
0.409x | -- |
About Merck Tbk
PT Merck Tbk engages in the manufacture and sale of pharmaceutical products in Indonesia and internationally. The company operates through Biopharma, Consumer Health, and Others segments. It offers health care products in the areas of cardiovascular, metabolic, oncology, endocrinology, fertility, and neurodegenerative diseases, as well as general medicines. The company also engages in research an… Read more